
ã»ãããã³ãGABAã®ç²Ÿç¥å®å®äœçšã¯çµå£æåã§ã¯åŸãããªãã£ãŠè©±ïŒè³ã®ã€ããïŒè§£ååŠããèãã
ã»ãããã³ãGABAã£ãŠããšãŠãã¡ãžã£ãŒãªèšèã«ãªã£ãŠããŸããããåã倧åŠçã®é ã«GABAãå«ãã ãã§ã³ã¬ãŒããæµè¡ãã ããŸãããã¡ããã©ãè¬çåŠããšããè¬ã®äœçšãåŠã¶ç§ç®ãå匷ããŠããŠãGABAã£ãŠç²Ÿç¥ç§é åã§ãšãŠãéèŠãªç©è³ªãªãã§ããããGABAã¯è¡æ¶²è³é¢éãééããªãããšæç§æžã«æžãããŠãããããã£ãããããGABAã£ãŠé£ã¹ãŠãæå³ãªããããïŒïŒãã£ãŠãªããŸããã仿¥ã¯ããã蟺ã«ã€ããŠåããããã解説ããããšæããŸãð
ïŒïŒïŒè³ã®ã€ããïŒãã¯ã
è³ã¯äººäœã®äžã§ãç¹æ®ã§äžæè°ãªèåšã§ããé éšã®ããªãã®å®¹ç©ãå ããéé㯠1200ïœ1500 g ãšäººäœã®äžã§ãæå€§ã¯ã©ã¹ã®å€§ããã§ãã
è³ãšèé«ãåãããŠäžæ¢ç¥çµãšåŒã°ããè³ãšèé«ãã现ãç¥çµãåºãŠããŠãããããæ«æ¢¢ç¥çµãšåŒã³ãŸããäžæ¢ç¥çµã¯é«èãšããç¹æ®ãªèã«èŠãããŠããŠãé«èã®äžã«ã¯è³è髿¶²ïŒé«æ¶²ïŒãšããéæãªæ¶²äœããããè³ãšäžæ¢ç¥çµã¯é«æ¶²ã®äžã«ããããæµ®éããç¶æ ã«ãªã£ãŠããŸãã
é«èã¯ãæå€å±€ã®ç¡¬ã硬èãäžéå±€ã®ã¯ã¢èãè³ãèé«ãçŽæ¥èŠãè»èã®ïŒå±€æ§é ãããªã£ãŠããŸãã髿¶²ã¯ã¯ã¢èäžè ã«ååšããŠããŸãã
ãã®æç¹ã§ããçšåºŠåããããšæããŸãããè³ãå«ãäžæ¢ç¥çµã¯ãåšå²ã®çµç¹ãããéçµ¶ããããç¹æ®ãªèåšãªã®ã§ãïŒ
è³ãæ é€ããŠããè¡ç®¡ç³»ã¯å€§ããïŒã€ã§ããåæ¹ã®å€§éšåãæ é€ããå é žåèç³»ãšåŸæ¹ã®äžéšãæ é€ããæ€éªšåèç³»ã§ããããã®ïŒã€ã®ç³»ãè³åºéšïŒè³ã®äžã®é¢ïŒã§èŒªã£ããäœã£ãŠè³å šäœã®æ é€ç³»ãæ¯ãã倧è³åè茪ïŒãŠã£ãªã¹åè茪ïŒã圢æããŸãã
è³ã®è¡ç®¡ç³»ã¯ãããã«ãå é žåèç³»ããå倧è³åèãšäžå€§è³åèãåºãŠããŠãäžå€§è³åèã倧è³ã®å€§åã®æ é€ãæ ã£ãŠããŸããæ€éªšåèç³»ããã¯æ°åã®å°è³åèãåºãåŸã§ãåŸå€§è³åèãåºãŠããŸããå€ãã®èåšã®åèã¯ãèåšã«çŽæ¥è¡æ¶²ãéãæ«æ¢¢éšåã«åã¶ãŸã§ãåèå士ãäºãã«ç¹ãã£ããè£ãåã£ãŠååžããŠããã®ã§ãïŒåã®åèãå€å°ãã¡ã«ãªã£ãŠããæ é€ãè¡ãå±ããŸããã§ããè³ã®åèç³»ã¯ãçµåèããšããããïŒåã®åèã䌞ã³ãå ã«ã¯ãã®åèããååžããŠããªãã®ã§ããã®åèããã¡ã«ãªããšããã®é åã«ã¯æ é€ãè¡ãå±ããªããªã£ãŠããŸããŸãããªããçµåèã§æåãªããïŒã€ã®èåšã¯å¿èã§ããã ãããè³ãå¿èã®è¡ç®¡ãè©°ãŸããšæ é€ããããªããªã£ãŠãè³æ¢å¡ãããå¿çæ¢å¡ããèµ·ããã®ã§ãã
ïŒïŒïŒè³ã®ã€ããïŒãã¯ã
ããŠããã¹ãŠã®èåšã§ãæ é€ã¯è¡ç®¡ã®äžãæµããè¡æ¶²ãéã³ãåèããéåžžã«çŽ°ãæ¯çŽ°è¡ç®¡ã«ç§»è¡ããŠãæ¯çްè¡ç®¡ããåšå²ã®çµç¹ã«æ é€ããã¿åºããŸããè³ã§ã¯æ¯çްè¡ç®¡ãšè³çµç¹ã®éã«éåžžã«åŒ·åºãªããªã¢ããããŸããããã¯è¡æ¶²è³é¢éïŒBlood-Brain Barrier: BBBïŒãšåŒã°ããŠããŸããããã¯èé«ã«ãããã®ã§ãå®è³ªçã«ãè¡æ¶²ãšè³è髿¶²ãšã®éã®ç©è³ªäº€æãå¶éããæ©æ§ãïŒè¡æ¶²è³é«æ¶²é¢éïŒBlood-CSF Barrier: BCSFBïŒãšããŠæ©èœããŠããŸãã
è¡æ¶²è³é¢éããããããã§ãè¡æ¶²ãšè³ã®éã®ç©è³ªäº€æãå¶éãããè³ã«æå®³ãªãã®ãåæã«å ¥ã£ãŠããªãããã«ãªã£ãŠããŸããäžæ¢ç¥çµã¯ç°å¢çã«éçµ¶ãããéåžžã«ç¹æ®ãªé åãªã®ã§ãã
ãã®ãããè³ã®ç æ°ã¯ããã°ãã°ä»ã®ç æ°ãšæ²»çãç°ãªã£ãŠããŸããããšãã°ãè³ã®ææçãæªæ§è «çã®æ²»çã«ã¯è¡æ¶²è³é¢éãééã§ããè¬å€ã䜿ããªããã°ãªããŸãããæªæ§ãªã³ãè «ã¯åºæ¬çã«è¡æ¶²å ç§ã§æ²»çãããã®ã§ãããè³ã®æªæ§ãªã³ãè «ã¯è³ç¥çµå€ç§ã§æ²»çãããã±ãŒã¹ãå€ãã®ã¯ãã®ããã§ãïŒå°åãç é¢ã«ããç°ãªããŸãïŒã
ç¥çµã¯ä¿¡å·ãäŒéããŠãèŠèŠãèŽèŠãè§ŠèŠãªã©ã®æèŠãäŒãããŸããçèãåãããŠéåããããããŸããè³å ã§ã¯è²ããªèããå·¡ããããè€éãªææ ãçã¿åºãããããããã§ãã
ä¿¡å·ãäŒéããã®ã¯ç¥çµçްèãšãããã现èã§ãç¥çµçްèã¯è»žçŽ¢ãšããé·ãçªèµ·ã䌞ã°ããŠé»æ°ä¿¡å·ãéããŸããç¥çµçްèã¯è³å ã§ã¯è€éã«ç¹ãããã£ãŠããŠãç¥çµçްèãšç¥çµçްèã®éã«ã¯ãã·ããã¹ããšããããã€ãªããããããŸãããã·ããã¹ãã§ã¯é»æ°ã§ã¯ãªããã·ããã¹åã®ç¥çµçްèããã·ããã¹ééã®äžã«æŸåºãããç¥çµäŒéç©è³ªãã·ããã¹åŸã®ç¥çµçްèãåãåã£ãŠãä¿¡å·ãäŒéããŸãã
ã»ãããã³ã GABA ãäž»èŠãªç¥çµäŒéç©è³ªã§ãããä»ã«ãã«ã¢ãã¬ããªã³ãããŒããã³ããã¹ã¿ãã³ãã¢ã»ãã«ã³ãªã³ãã°ã«ã¿ãã³é žãªã©ãæåã§ãã
ïŒïŒïŒã»ãããã³ãšè³ã®é¢ä¿
ã»ãããã³ã¯äººäœå ã«ã¯çŽ 10 mg ååšããæ¶å管ç²èã« 90ïŒ ãè¡å°æ¿ã« 8ïŒ ãè³ã« 2ïŒ ååšããŠããŸããé£äºãæããšæ¶å管ã§ã»ãããã³ãç£çãããè žè åã«é¢äžããŸããããããæ¶å管ã§ç£çãããã»ãããã³ã¯è¡æ¶²è³é¢éãééããŸãããè³ã®ç¥çµäŒéç©è³ªãšããŠåãã»ãããã³ã¯è³å¹¹ã®çž«ç·æ žã§äœãããŸãã
ã»ãããã³ã¯ãå¿
é ã¢ããé
žã§ããããªãããã¡ã³ããåæãããŸãããã®ãããè³ã®ã»ãããã³ã«åæã«ã¯ããªãããã¡ã³ã®æåãéèŠã§ãããããªãããã¡ã³ã®æåããå®éã«ã»ãããã³ãåæãããŸã§ã«ã¯å€å°æéããããã¯ããªã®ã§ãããªãããã¡ã³ãå«ãé£äºãæåããŠããã«è³ã®ã»ãããã³ç³»ã«äœçšããããšã¯èãã«ãããšæãããŸããå³å¹çãªå¹æãšããããããæ
¢æ§çãªããªãããã¡ã³ã®äžè¶³ãæ
¢æ§çãªã»ãããã³ã®äžè¶³ã«ã€ãªããå¯èœæ§ããããšèããã®ããªãŒãºããã«ã§ããããã®ç¹ã«ã€ããŠè©³çްã¯åãäžããªãã®ã§ãç¥ã£ãŠããæ¹ããããæããŠããã ãããšå¹žãã§ãã
è³ã§ç¥çµäŒéç©è³ªãšããŠã®ã»ãããã³ãäžè¶³ãããšããã€ç ãäžå®é害ãªã©ã®æ§ã ãªç²Ÿç¥çŸæ£ãçºçããŸããæè¿ã§ã¯ããã®ã»ãããã³ã®äžè¶³ãè§£æ¶ããŠç æ°ãæ²»çããããã«ãéžæçã»ãããã³ååã蟌ã¿é»å®³è¬ïŒSelective Serotonin Reuptake Inhibitors: SSRIïŒãçšããããŸããã·ããã¹åã®ç¥çµçްèããæŸåºãããã»ãããã³ã¯ãåã³ç¥çµçްèã«åžåãããã®ã§ããããã®åžåãé»å®³ããããšã§ãã·ããã¹ééã®äžã®ã»ãããã³æ¿åºŠãé«ããåããããŸããåŸæ¥ã®æãã€è¬ã«æ¯ããŠå¯äœçšãå°ãªããã®ã®ãå¯äœçšããªãããã§ã¯ãªãã®ã§æ³šæãå¿ èŠã§ããã䜿çšã¯å°éå®¶ã®æå°ã®äžã§è¡ãã¹ããšèããŸãã
ïŒïŒïŒGABA ãšè³ã®é¢ä¿
GABAïŒã®ã£ãïŒãšã¯ γ-ã¢ããé ªé žïŒã¬ã³ã-ã¢ãããããããgamma-aminobutyric acidïŒã®ããšã§ãåºæ¬çã«æå¶æ§ã®ç¥çµäŒéç©è³ªãšããŠåããé®éãæçæ£ãæäžå®äœçšãªã©ãæããŠããŸãããããŠãåé ã§è¿°ã¹ãéãã
GABA ã¯è¡æ¶²è³é¢éãééããªãç©è³ªã§ãããäœå€ãã GABA ãæåããŠãããããç¥çµäŒéç©è³ªãšããŠãã®ãŸãŸçšããããããšã¯ãããŸããã
ãGABA ã¯æ°æã¡ãèœã¡çããã广ãããããšèšã£ãŠãçµå£æåãä¿ãååããããããã«ãããã«ãç§åŠçãªæ ¹æ ããããããªãããã¬ã³ããçšããŠãæ§ã ãªååããã§ã€ã¯èšäºãããµããŠããŸãããŸããããã«äŒŽã£ãŠããã§ã€ã¯ãä¿¡ããåè¯ãªäººã«ãã£ãŠäºæ¬¡çãã§ã€ã¯ãåºãã£ãŠããã®ãçŸç¶ã§ããããã¯åããšããã³ã¹ã«åºã¥ããåžžèçãªçºä¿¡ãåºããããšæãçç±ã§ããããŸãã
å®éã®å»ççŸå Žã§ã¯é®éãæå¶ã®å¹æãåŒãåºãããã«ã¯ããã¡ããšè¡æ¶²è³é¢éãééãã GABA äœåè¬ïŒGABA ã®åãã匷ããè¬ïŒãçšããããŸãããã®ä»£è¡šããã«ãããŒã«é žç³»ãšãã³ãŸãžã¢ãŒãã³ç³»ã§ãããæè¿ã¯ãã³ãŸãžã¢ãŒãã³ç³»ãå€ãçšããããŠããŸããã¡ãªã¿ã«ãäœæ ãæ§é ãè€éãªãã³ãŸãžã¢ãŒãã³ç³»è¬å€ãè¡æ¶²è³é¢éãééã㊠GABA ãã®ãã®ãééããªãã®ãã¯ç¥ããŸããïŒèå容äœã»ãã©ã³ã¹ããŒã¿ãŒã®åé¡ãªæ°ãããŸãããç¥ã£ãŠãæ¹ããããæããŠããã ãããšå¬ããã§ãïŒã
ãã³ãŸãžã¢ãŒãã³ç³»ã«ã¯éåžžã«å€ãã®çš®é¡ã®è¬å€ããããç®çã»çšéã«ãã£ãŠäœ¿ãåããããŠãããŸããäžéšã®äœ¿çšäŸã以äžã«ç€ºããŸãïŒäž»ã«åã䜿çšããããšã®ãããã®ã§ãïŒãäžéšã¯éè€ããŠããŸãããä»ã®äœ¿çšæ³ããããŸãããä»ã®è¬å€ããããŸãã
ãææ¥çŸå Žã§ã®æçæ£ã»æäžå®ãªã©ïŒäž»ã«æ³šå°ïŒã
â¶ ãžã¢ãŒãã ïŒã»ã«ã·ã³ãããªãŸã³ïŒ
ãå èŠé¡ãæ°ç®¡æ¿ç®¡æã®é®éãªã©ã
â¶ ãããŸã©ã ïŒãã«ãã«ã ïŒ
ã宿çãªæäžå®äœçšãªã©ïŒäž»ã«å æïŒã
â¶Â ã¢ã«ãã©ãŸã©ã ïŒãœã©ããã¯ã¹ïŒ
â¶Â ã¯ãããŒãã ïŒãªãããªãŒã«ïŒ
â¶Â ã¯ããã¢ãŒãã ïŒãªãŒãŒïŒ
â¶Â ãšããŸã©ã ïŒããã¹ïŒ
â¶Â ããã©ãŒãé žãšãã«ïŒã¡ã€ã©ãã¯ã¹ïŒ
ãç¡ç å°å ¥è¬ã
â¶Â ããããŸã©ã ïŒã¬ã³ãã«ãã³ãã°ãããã³ïŒ
â¶ ãšããŸã©ã ïŒããã¹ïŒ
â¶Â ãã«ããã©ãŒãã ïŒãµã€ã¬ãŒã¹ïŒ
â¶Â ãã©ãŒãã ïŒã¯ã€ããã¯ã¹ïŒ
â¶Â ããªã¢ãŸã©ã ïŒãã«ã·ãªã³ïŒ
â» ä»ã«æçæ£è¬ãšããŠæ®æ®µã®å æã§çšããå ŽåããããŸãããã¯ãããŒãã ïŒãªãããªãŒã«ïŒã¯ãããããèçå矀ãã«ãçšããããŸãã
ãã³ãŸãžã¢ãŒãã³ç³»ã¯äŸåçããŸããè¬å€æžéã«ããé¢è±çç¶ãåé¡ãšãªãè¬å€ã§ããããã䜿çšã¯å°éå®¶ã®æå°ã®äžã§è¡ãã¹ãã§ããæ ¹æ¬çã«ã¯äœã«è¯ããã®ã§ã¯ãªããšæããŸããïŒãããªãã«å¯äœçšãæå®³äºè±¡ããããŸãïŒãä»ãçãæãããã«å¿ èŠãªäººã«ã¯å¿ èŠã§ãã®ã§ããã¡ããšããå°éå®¶ã®åŠæ¹ã®äžã§ãé©ããçç¶ã«å¯ŸããŠçšããããã¹ãè¬å€ã§ããåæžæã«ãã£ãŠãçæéãäžæéãé·æéäœçšåã«åé¡ãããŸãããåæžæãçãã»ã©å¹ãç®ãããããªåãããè¬å€ã®å¹æã®åãç®ãåãããããã§ããåæžæãé·ãã»ã©ãã£ãããšãã广ããããŸãããé·ææçšã«ããäŸåãé¢è±çç¶ãçãããããšãããŠããŸãã
ïŒïŒïŒãŸãšã
ïŒïŒè³ã¯åšå²èåšããéçµ¶ãããç¹å¥ãªç°å¢ã«ãããè¡æ¶²è³é¢éïŒBlood-Brain Barrier: BBBïŒã«ãã£ãŠæ¯çްè¡ç®¡ãšã®ç©è³ªäº€æãå¶éãããŠãã
ïŒïŒç¥çµä¿¡å·ã¯è»žçŽ¢ãäŒã黿°çä¿¡å·ãšç¥çµçްèã®ã€ãªãããã·ããã¹ãã§ã®ååŠçäŒéããããã»ãããã³ã GABA ã¯ã·ããã¹ã§ã®ååŠçäŒéãæ ãç¥çµäŒéç©è³ªã§ãã
ïŒïŒã»ãããã³ã GABA ãè¡æ¶²è³é¢éãééã§ããªãã®ã§é£äºãªã©ã§çµå£æåããŠãæå³ããªããå¿ èŠãªç æ°ã§ã¯ãããã®ç©è³ªã®åããå©ããè¬ïŒäœåè¬ïŒã§ãã SSRI ããã³ãŸãžã¢ãŒãã³ãçšãã â 䜿çšã¯å°éå®¶ã®æå°äžã§è¡ãã¹ãã§ãã
â» ãªããåèªèº«ããããã¯é害ã®ãã SSRIïŒãããã»ãã³ïŒããã³ãã³ãŸãžã¢ãŒãã³ãçšããŠããŸãããã³ãŸãžã¢ãŒãã³ã¯é·ããã¢ã«ãã©ãŸã©ã ïŒãœã©ããã¯ã¹ïŒã䜿çšããŠããŸããããçŸåšã¯ SSRI ã®å¯äœçšã§ã¬ã ç¡ç è¡åé害ã»ããããèçå矀ãçããŠããããããã³ãŸãžã¢ãŒãã³ç³»ãã¯ãããŒãã ïŒãªãããªãŒã«ïŒã«å€æŽããŸãããå¯äœçšã«å¯Ÿã㊠SSRI ã®æžè¬ã詊ã¿ã€ã€ãä»ã®è¬å€ïŒãã©ããããœãŒã«å¡©é žå¡©æ°Žåç©/ãã»ã·ãããŒã«ïŒã䜵çšããŠããŸãã
ïŒïŒïŒãµãŒã¯ã«ç޹ä»
ïŒïŒç
çå»ãã€ãªãå»çã®æ¶ãæ©
ããæ£ç¢ºãªå»çç¥èãå
±æããŸãããïŒå»çæ
å ±ã®åæšéžæãéã¿ã¥ããªã©ãè¡ãããããªãããšãåããã«ããå»çã®äžçããç
çå»ã®èŠç¹ããã€ãªããŸãã
ïŒïŒæ°åŠååŠã¹ã¯ãŒã«
çŸåœ¹å¥³å倧çã®ðæ¡åðãããéå¶ããæ°åŠãååŠã«ã€ããŠèªãåããµãŒã¯ã«ãã¢ããã³ãã«ã¬ã³ããŒäŒç»ãåºããŠãã ãã£ãã³ãã«ããwithã¢ã€å
çðãæå±ããŠããŸãð
éç
çé¢é£é åïŒç²Ÿç¥ç§ã»äžè¬å°å
ã»ç·åå
ç§ã»ææ¥ãªã©ïŒã®å»åŠæ
å ±ã¯ãã¡ãã«ãŸãšããŠããŸã
ãç çå»ãã®ãŒãšãã¡ãã¥ãŒ
ðãç çå»ãã®ãŒãšãã®èªå·±ç޹ä»
ðãç çå»ãã®ãŒãšãã®ãµã€ãããã
ðãSANOTIC ARCHIVESãå»çç³»ãµã€ãããã
 #ç çå»ãã®ãŒãš #ç ç蚺æ #ç çåŠ #å»åŠ #å»ç #ç§ã®ä»äº #ããŸç§ã«ã§ããããš #ç çå»ãã€ãªãå»çã®æ¶ãæ© #æ°åŠååŠã¹ã¯ãŒã« #æ¡å #ã¢ã€å ç #粟ç¥ç§ #粟ç¥å»åŠ #è³ #ç¥çµ #ç¥çµäŒéç©è³ª #GABA #ã»ãããã³ #ççåŠ #è¬çåŠ #åºç€å»åŠ #粟ç¥çŸæ£ #äžç ç #äžå® #æäžå®è¬ #ãã³ãŸãžã¢ãŒãã³ #ç¥çµççåŠ #ã·ããã¹ #ç¥çµçްè #è§£ååŠ #çµç¹åŠ #ããããèçå矀 Â
- #äžå®
- #ç§ã®ä»äº
- #ããŸç§ã«ã§ããããš
- #粟ç¥çŸæ£
- #å»ç
- #粟ç¥ç§
- #è³
- #äžç ç
- #ã»ãããã³
- #å»åŠ
- #è§£ååŠ
- #ç¥çµ
- #粟ç¥å»åŠ
- #ã·ããã¹
- #ã¢ã€å ç
- #ççåŠ
- #ãã³ãŸãžã¢ãŒãã³
- #ç çåŠ
- #æäžå®è¬
- #GABA
- #ç¥çµäŒéç©è³ª
- #ç¥çµçްè
- #è¬çåŠ
- #ç ç蚺æ
- #ããããèçå矀
- #åºç€å»åŠ
- #ç¥çµççåŠ
- #æ¡å
- #ç çå»ãã®ãŒãš
- #çµç¹åŠ
- #ç çå»ãã€ãªãå»çã®æ¶ãæ©
- #æ°åŠååŠã¹ã¯ãŒã«